Literature DB >> 16389133

Stroke prevention, treatment, and rehabilitation in sub-saharan Africa.

Daniel Lemogoum1, Jean-Paul Degaute, Pascal Bovet.   

Abstract

Stroke is emerging as a leading cause of preventable death and disability in adults in many developing nations. In Sub-Saharan Africa (SSA), stroke mortality and case fatality in some countries exceed those in the developed world. Stroke also occurs at much earlier ages in SSA, resulting in a greater number of years of potential life lost. The high social and economic burden of stroke calls for effective strategies for prevention, treatment, and rehabilitation in SSA. High blood pressure is the most powerful predictor of stroke, and its treatment can reduce the risk of stroke by > or = 40%. Effective stroke prevention calls for comprehensive risk reduction including blood pressure control. Population-based health education programs and appropriate public health policy coupled with high-risk strategies targeting hypertensive persons and stroke patients must be developed. A broad partnership of key players, innovative funding mechanisms, and increased national and international commitment for the prevention and control of stroke in sub-Saharan Africa and other developing countries is needed.

Entities:  

Mesh:

Year:  2005        PMID: 16389133     DOI: 10.1016/j.amepre.2005.07.025

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  34 in total

1.  Stroke subtypes and factors associated with ischemic stroke in Kinshasa, Central Africa.

Authors:  Michel Lelo Tshikwela; Fifi Baza Londa; Stéphane Yanda Tongo
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

2.  One-Year Rates and Determinants of Poststroke Systolic Blood Pressure Control among Ghanaians.

Authors:  Fred Stephen Sarfo; Gloria Kyem; Bruce Ovbiagele; John Akassi; Osei Sarfo-Kantanka; Martin Agyei; Elizabeth Badu; Nathaniel Adusei Mensah
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-09-14       Impact factor: 2.136

3.  Perceived and experienced restrictions in participation and autonomy among adult survivors of stroke in Ghana.

Authors:  S L Amosun; G G Nyante; E K Wiredu
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

4.  Surviving stroke in an Ebola Treatment Centre.

Authors:  Paul Dhillon; Sinead McCarthy; Michael Gibbs
Journal:  BMJ Case Rep       Date:  2015-10-29

5.  Assessing Mobile Health Capacity and Task Shifting Strategies to Improve Hypertension Among Ghanaian Stroke Survivors.

Authors:  Michelle Nichols; Fred Stephen Sarfo; Arti Singh; Suparna Qanungo; Frank Treiber; Bruce Ovbiagele; Raelle Saulson; Sachin Patel; Carolyn Jenkins
Journal:  Am J Med Sci       Date:  2017-08-12       Impact factor: 2.378

6.  Stroke-Risk Factors Differ between Rural and Urban Communities: Population Survey in Central Uganda.

Authors:  Jane Nakibuuka; Martha Sajatovic; Joaniter Nankabirwa; Anthony J Furlan; James Kayima; Edward Ddumba; Elly Katabira; Jayne Byakika-Tusiime
Journal:  Neuroepidemiology       Date:  2015-05-07       Impact factor: 3.282

Review 7.  Phone-based intervention under nurse guidance after stroke: concept for lowering blood pressure after stroke in Sub-Saharan Africa.

Authors:  Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-10-24       Impact factor: 2.136

8.  Poststroke hypertension in Africa.

Authors:  Martin Kaddumukasa; Edward Ddumba; Pamela Duncan; Larry B Goldstein
Journal:  Stroke       Date:  2012-09-25       Impact factor: 7.914

9.  Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke (THRIVES) study: qualitative phase protocol.

Authors:  Mayowa O Owolabi; Rufus O Akinyemi; Samantha Hurst; Oyedunni Arulogun; Olanrewaju Olaniyan; Mulugeta Gebregziabher; Babatunde L Salako; Bruce Ovbiagele
Journal:  Crit Pathw Cardiol       Date:  2014-03

10.  Hypertensive target organ damage in Ghanaian civil servants with hypertension.

Authors:  Juliet Addo; Liam Smeeth; David A Leon
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.